Connecticut Attorney General William Tong announced four separate settlements with hearing aid companies: Lively Hearing Corporation, Widex USA, Inc., Hark Wellness, Inc., and Wonder Ear, Inc., who marketed their products as “FDA-approved” despite no such approval.
Hearing aids currently do not receive approval from the United States Food and Drug Administration (FDA) in the same manner as new drugs and some medical devices; however, hearing aid manufacturers register their products with the FDA.
Although Congress enacted legislation in 2017 permitting the FDA to create a category of over-the-counter (OTC) hearing aids, the FDA has not yet issued a final rule and no hearing aid suppliers should be marketing their products as OTC or “FDA-approved.”
Related Posts
CMS Issues Final Rule to Improve Access, Accountability, and Transparency in Medicaid Managed Care
The Centers for Medicare and Medicaid (CMS) recently issued a final rule aimed at improving access to care, accountability and transparency for the more than 70…
April 2024 State Legislative Update
In early April, as 19 state legislatures concluded their sessions for the year, a flurry of legislative activity marked the landscape, particularly in audiology and…
Medicare Advantage Plans Now Required to Inform Beneficiaries of Hearing Benefits
On April 4, 2024, the Centers for Medicare and Medicaid Services (CMS) issued a final rule that updates the Medicare Advantage Program for 2025. In…